PGEN EBITDA | PRECIGEN, INC.

PRECIGEN, INC. (PGEN) EBITDA

2026-06-30: Basis Reported; EBITDA $23.74M*; Operating income $22.64M; Depreciation and amortization $1.10M*.
2026-03-31: Basis Reported; EBITDA -$4.9M; Operating income (m); Depreciation and amortization (m).
2025-06-30: Basis Reported; EBITDA -$31.13M*; Operating income -$31.76M; Depreciation and amortization $630.00K*.
2025-03-31: Basis Reported; EBITDA -$21.97M; Operating income (m); Depreciation and amortization (m).

Complete source-backed ebitda history.

Available history: 2012-12-31 to 2026-03-31
Data captured: 2026-09-04

Historical EBITDA

EBITDA 3 month

Date	Basis	EBITDA	Operating income	Depreciation and amortization	Revenue	EBITDA margin	Capital spending	Operating cash flow	Cost of products and services	Research and development	Selling, general and administration	Income tax expense / benefit
2026-06-30	Reported	$23.74M*	$22.64M	$1.10M*	$54.98M	43.19%*	$392.00K*	-$17.81M*	(m)	$7.28M	$22.25M	$0.00
2026-03-31	Reported	-$4.9M	(m)	(m)	(m)	-21.05%	$258.00K	-$43.83M	(m)	$5.64M	$21.05M	$0.00
2025-06-30	Reported	-$31.13M*	-$31.76M	$630.00K*	$856.00K	-3637.15%*	$966.00K*	-$18.98M*	(m)	$11.49M	$16.13M	$3.00K
2025-03-31	Reported	-$21.97M	(m)	(m)	(m)	-1638.11%	$622.00K	-$16.32M	(m)	$10.48M	$12.36M	$0.00
2024-03-31	Reported	(m)	(m)	$1.59M	(m)	(m)	$4.35M	-$14.09M	(m)	(m)	(m)	-$29.00K
2023-03-31	Reported	(m)	(m)	$1.71M	$1.85M	(m)	$154.00K	-$18.39M	(m)	(m)	(m)	-$55.00K
2022-03-31	Reported	(m)	(m)	$3.29M	$5.51M	(m)	$1.58M	-$18.78M	(m)	(m)	(m)	-$58.00K
2021-03-31	Reported	(m)	(m)	$3.52M	$24.51M	(m)	$1.01M	-$16.38M	(m)	(m)	(m)	(m)
2020-12-31	Reported	(m)	-$35.17M	(m)	$19.33M	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2020-09-30	Reported	-$18.90M*	-$23.01M	$4.11M*	$23.58M	-80.13%*	$1.02M*	-$19.00M*	(m)	(m)	(m)	(m)
2020-06-30	Reported	-$7.05M*	-$11.83M	$4.78M*	$30.42M	-23.16%*	$1.88M*	-$13.80M*	(m)	(m)	(m)	(m)
2020-03-31	Reported	-$11.79M*	-$16.60M	$4.81M	$29.84M	-39.51%*	$3.15M	-$27.74M	(m)	(m)	(m)	(m)
2019-12-31	Reported	(m)	-$68.72M	(m)	$17.00M	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2019-09-30	Reported	-$28.68M*	-$34.70M	$6.02M*	$18.30M	-156.74%*	$7.78M*	-$27.15M*	(m)	$31.48M	$24.74M	-$512.00K
2019-06-30	Reported	-$15.39M*	-$21.51M	$6.11M*	$32.84M	-46.88%*	$13.90M*	-$33.40M*	(m)	$34.52M	$21.48M	-$525.00K
2019-03-31	Reported	-$52.13M	(m)	(m)	(m)	-230.80%	$11.52M	-$43.23M	(m)	$33.06M	$33.59M	-$578.00K
2018-12-31	Reported	-$328.95M	(m)	(m)	(m)	-973.55%	(m)	(m)	(m)	(m)	(m)	(m)
2018-09-30	Reported	-$50.03M*	-$58.33M	$8.30M*	$32.45M	-154.18%*	$8.77M*	-$28.82M*	(m)	$44.88M	$38.71M	-$14.32M
2018-06-30	Reported	-$26.31M*	-$34.81M	$8.50M*	$45.27M	-58.11%*	$10.81M*	-$28.17M*	(m)	$42.05M	$34.43M	-$1.13M
2018-03-31	Reported	-$44.27M	(m)	(m)	(m)	-111.60%	$10.77M	-$29.89M	(m)	$37.27M	$39.74M	-$4.09M
2017-12-31	Reported	-$18.23M	(m)	(m)	(m)	-27.82%	(m)	(m)	(m)	(m)	(m)	(m)
2017-09-30	Reported	-$36.76M*	-$44.75M	$7.99M*	$46.02M	-79.88%*	$14.41M*	-$22.01M*	(m)	$36.47M	$39.28M	-$818.00K
2017-06-30	Reported	-$27.78M*	-$35.27M	$7.49M*	(m)	(m)	$11.92M*	-$23.14M*	(m)	$34.01M	$38.84M	-$813.00K
2017-03-31	Reported	-$23.98M	(m)	(m)	(m)	-44.62%	$6.34M	-$24.69M	(m)	$34.18M	$35.14M	-$533.00K
2016-12-31	Reported	-$25.68M	(m)	(m)	(m)	-55.81%	(m)	(m)	(m)	(m)	(m)	(m)
2016-09-30	Reported	-$22.84M*	-$28.82M	$5.98M*	(m)	(m)	$10.16M*	-$15.73M*	(m)	$29.04M	$33.81M	-$418.00K
2016-06-30	Reported	-$17.20M*	-$23.22M	$6.03M*	(m)	(m)	$5.78M*	-$12.44M*	(m)	$28.38M	$30.26M	-$591.00K
2016-03-31	Reported	-$34.89M	(m)	(m)	(m)	-80.31%	$4.26M	-$3.61M	(m)	$25.86M	$42.88M	-$2.28M
2015-12-31	Reported	-$28.85M	(m)	(m)	(m)	-69.53%	(m)	(m)	(m)	(m)	(m)	(m)
2015-09-30	Reported	-$3.07M*	-$7.92M	$4.84M*	(m)	(m)	$3.10M*	$52.90M*	(m)	$21.60M	$23.02M	-$923.00K
2015-06-30	Reported	-$13.62M*	-$17.43M	$3.81M*	(m)	(m)	$4.03M*	-$16.52M*	(m)	$20.38M	$23.67M	$934.00K
2015-03-31	Reported	-$83.57M	(m)	(m)	(m)	-246.90%	$2.71M	-$13.04M	(m)	$79.31M	$27.63M	$795.00K
2014-12-31	Reported	-$15.42M	(m)	(m)	(m)	-49.58%	(m)	(m)	(m)	(m)	(m)	(m)
2014-09-30	Reported	-$11.95M*	-$15.05M	$3.10M*	(m)	(m)	$1.44M*	(m)	(m)	$14.85M	$14.85M	$0.00
2014-06-30	Reported	-$16.11M*	-$18.08M	$1.97M*	(m)	(m)	$769.00K*	(m)	(m)	$14.43M	$15.38M	-$283.00K
2014-03-31	Reported	-$16.07M	(m)	(m)	(m)	-204.57%	$2.98M	(m)	(m)	$12.06M	$13.63M	$306.00K
2013-12-31	Reported	-$15.98M	(m)	(m)	(m)	-223.74%	(m)	(m)	(m)	(m)	(m)	(m)
2013-09-30	Reported	(m)	-$12.04M	(m)	(m)	(m)	(m)	(m)	(m)	$10.76M	(m)	$0.00
2013-09-30	Reported	(m)	-$12.04M	(m)	(m)	(m)	$486.00K*	-$15.85M*	(m)	$10.67M	$7.41M	$0.00
2013-06-30	Reported	(m)	-$14.25M	(m)	(m)	(m)	$595.00K*	(m)	(m)	$13.51M	(m)	$0.00
2013-03-31	Reported	(m)	-$14.01M	(m)	(m)	(m)	$181.00K	(m)	(m)	$11.41M	(m)	$0.00
2012-12-31	Reported	(m)	-$12.30M	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2012-09-30	Reported	(m)	-$16.48M	(m)	(m)	(m)	$180.00K*	-$15.28M*	(m)	$14.36M	(m)	$0.00
2012-06-30	Reported	(m)	-$21.25M	(m)	(m)	(m)	(m)	(m)	(m)	$17.64M	(m)	$0.00
2012-03-31	Reported	(m)	-$25.12M	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)

EBITDA 12 month

Date	Basis	EBITDA	Operating income	Depreciation and amortization	Revenue	EBITDA margin	Capital spending	Operating cash flow	Cost of products and services	Research and development	Selling, general and administration	Income tax expense / benefit
2025-12-31	Reported	-$107.31M	(m)	(m)	(m)	-1108.10%	$2.00M	-$87.83M	(m)	$41.33M	$70.13M	$3.00K
2024-12-31	Reported	-$130.5M	(m)	(m)	(m)	-3324.92%	$8.58M	-$68.17M	(m)	$53.07M	$41.29M	-$1.79M
2023-12-31	Reported	-$93.09M	(m)	(m)	(m)	-1495.42%	$1.54M	-$66.93M	(m)	$48.61M	$40.41M	-$458.00K
2022-12-31	Reported	(m)	(m)	$10.77M	$26.91M	(m)	$4.92M	-$65.05M	(m)	(m)	(m)	-$189.00K
2021-12-31	Reported	(m)	(m)	$13.76M	$14.27M	(m)	$7.25M	-$55.77M	(m)	(m)	(m)	-$160.00K
2021-03-31	Rolling	(m)	(m)	(m)	$97.85M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2020-12-31	Reported	(m)	(m)	$17.52M	$31.99M	(m)	$7.53M	-$77.02M	(m)	(m)	(m)	-$82.00K
2020-12-31	Rolling	(m)	-$86.60M*	(m)	$103.18M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2020-09-30	Rolling	(m)	-$120.16M*	(m)	$100.85M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2020-06-30	Rolling	(m)	-$131.86M*	(m)	$95.56M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2020-03-31	Rolling	(m)	-$141.53M*	(m)	$97.97M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2019-12-31	Reported	(m)	(m)	$24.90M	$90.72M	(m)	$37.88M	-$135.93M	(m)	(m)	(m)	-$930.00K
2019-12-31	Rolling	(m)	-$166.79M*	(m)	$90.72M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2019-09-30	Rolling	(m)	-$366.18M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2019-06-30	Rolling	(m)	-$389.81M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2019-03-31	Rolling	(m)	-$403.11M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2018-12-31	Reported	-$472.5M	(m)	(m)	(m)	-312.54%	$41.59M	-$124.24M	(m)	$404.59M	$137.81M	-$15.43M
2018-12-31	Rolling	(m)	-$403.50M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2018-09-30	Rolling	(m)	-$161.87M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2018-06-30	Rolling	(m)	-$148.29M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2018-03-31	Rolling	(m)	-$148.75M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2017-12-31	Reported	-$106.75M	(m)	(m)	(m)	-48.64%	$46.67M	-$103.72M	(m)	$143.21M	$146.10M	$2.07M
2017-12-31	Rolling	(m)	-$137.89M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2017-09-30	Rolling	(m)	-$143.99M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2017-06-30	Rolling	(m)	-$128.06M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2017-03-31	Rolling	(m)	-$116.01M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2016-12-31	Reported	-$100.59M	(m)	(m)	(m)	-52.69%	$31.63M	-$48.99M	(m)	$112.14M	$142.32M	-$3.88M
2016-12-31	Rolling	(m)	-$125.17M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2016-09-30	Rolling	(m)	-$126.97M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2016-06-30	Rolling	(m)	-$106.07M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2016-03-31	Rolling	(m)	-$100.27M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2015-12-31	Reported	-$129.12M	(m)	(m)	(m)	-74.38%	$12.75M	$35.67M	(m)	$147.48M	$109.06M	$1.02M
2015-12-31	Rolling	(m)	-$146.86M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2015-09-30	Rolling	(m)	-$131.43M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2015-06-30	Rolling	(m)	-$138.56M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2015-03-31	Rolling	(m)	-$139.21M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2014-12-31	Reported	-$59.55M	(m)	(m)	(m)	-82.78%	$6.37M	-$19.86M	(m)	$58.98M	$63.65M	-$103.00K
2014-12-31	Rolling	(m)	-$69.96M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2014-09-30	Rolling	(m)	-$68.73M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2013-12-31	Reported	-$50.82M	(m)	(m)	(m)	-213.88%	$1.53M	-$53.68M	(m)	$48.14M	$33.62M	$0.00
2013-06-30	Rolling	(m)	-$57.05M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2013-03-31	Rolling	(m)	-$64.04M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2012-12-31	Reported	-$67.17M	(m)	(m)	(m)	-487.68%	$7.49M	-$61.53M	(m)	$64.03M	$24.90M	$0.00
2012-12-31	Rolling	(m)	-$75.16M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2011-12-31	Reported	(m)	-$82.43M	(m)	(m)	(m)	$13.00M	-$81.76M	(m)	$70.23M	(m)	$0.00

Similar stocks

Stock Name	Country	Market Cap	PE Ratio
NewAmsterdam Pharma Co N.V. (NAMS)		$2.719B	-15.37
MBX Biosciences, Inc. (MBX)	United States	$2.664B	-25.36
Disc Medicine, Inc. (IRON)	United States	$2.553B	-11.40
Immunome Inc. (IMNM)	United States	$2.538B	-9.45
SUPERNUS PHARMACEUTICALS, INC. (SUPN)	United States	$2.517B	-24.63
Nurix Therapeutics, Inc. (NRIX)	United States	$2.457B	-5.39
Dyne Therapeutics, Inc. (DYN)	United States	$3.084B	-7.09
SELLAS Life Sciences Group, Inc. (SLS)	United States	$2.420B	-91.87
uniQure N.V. (QURE)		$2.416B	-4.93
Vera Therapeutics, Inc. (VERA)	United States	$2.402B	-7.67